GENE ONLINE|News &
Opinion
Blog

2021-11-15|

9 Leading Molecular Diagnostics Companies to Watch in Taiwan

by Joy Lin
Share To
Molecular diagnosis is a pillar of precision medicine. Capable of predicting treatment effects through a comprehensive analysis of the patient's condition, the approach allows optimal drug selection to slash time and cost for recovery.

Furthermore, periodic screening for biomarkers could detect disease in the early stages, giving much-needed time for prompt treatment that could improve the survival rate of patients. And more importantly, accurate screening helps clinical drug development. These advantages prove how important molecular diagnostics are to modern society.

Taiwan is highly active in the area of in-vitro diagnostics research and development, having launched numerous tests for the world's most popular diseases. In this article, we list 9 companies that will give a quick snapshot of the island's molecular diagnostics industry.

GO Prime with only $1.49 now

LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Scroll to Top